12/19/2024
11:15 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form EFFECT | |
12/10/2024
1:27 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/22/2024
4:28 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/21/2024
4:10 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K/A | |
11/14/2024
3:25 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
4:10 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
3:55 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/24/2024
4:06 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/22/2024
3:35 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:05 PM | Braeden Lichti (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/09/2024
3:10 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form DEFA14A | |
10/09/2024
3:10 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
4:10 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:15 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
2:46 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 424B4 | |
09/05/2024
8:25 AM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
11:15 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form EFFECT | |
08/22/2024
3:41 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form S-1/A | |
08/09/2024
5:15 AM | BECHER CAMPBELL (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:28 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form S-1/A | |
07/25/2024
10:57 AM | PRICE CODY (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:00 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
8:47 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form PRE 14A | |
07/15/2024
4:06 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
5:15 AM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
4:25 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
2:35 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:05 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form NT 10-Q | |
05/03/2024
7:59 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form S-1/A | |
05/02/2024
11:15 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form EFFECT | |
04/05/2024
8:59 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
1:35 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form NT 10-K | |
03/28/2024
3:05 PM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:00 AM | Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
